Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate
Crossref DOI link: https://doi.org/10.1186/s13550-016-0162-2
Published Online: 2016-01-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chan, Ho Sze
Konijnenberg, Mark W.
de Blois, Erik
Koelewijn, Stuart
Baum, Richard P.
Morgenstern, Alfred
Bruchertseifer, Frank
Breeman, Wouter A.
de Jong, Marion
Funding for this research was provided by:
DINSE Stiftung
License valid from 2016-01-20